Associated Papers
TGFβ signalling acts as a molecular brake of myoblast fusion.
Melendez J et al.
Nature Communications, 2021
Genetic profiling and cardiovascular phenotypic spectrum in a Chinese cohort of Loeys-Dietz syndrome patients.
Yang H et al.
Orphanet Journal of Rare Diseases, 2020
Targeted sequencing of cancer-related genes in nasopharyngeal carcinoma identifies mutations in the TGF-β pathway.
Chung AK et al.
Cancer Medicine, 2019
TGF-β triggers rapid fibrillogenesis via a novel TβRII-dependent fibronectin-trafficking mechanism.
Varadaraj A et al.
Molecular Biology of the Cell, 2017
Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer.
Ashktorab H et al.
Oncotarget, 2017
28002797 (PubMed )
Supplement: oncotarget-08-7852-s002.xlsx › TGFBR2.Ion
Molecular modeling and molecular dynamic simulation of the effects of variants in the TGFBR2 kinase domain as a paradigm for interpretation of variants obtained by next generation sequencing.
Zimmermann MT et al.
Plos One, 2017
Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II.
Song K et al.
The Journal of Biological Chemistry, 2006
A 7.1 kbp beta-myosin heavy chain promoter, efficient for green fluorescent protein expression, probably induces lethality when overexpressing a mutated transforming growth factor-beta type II receptor in transgenic mice.
Allegra S et al.
Transgenic Research, 2005
Smads in human trophoblast cells: expression, regulation and role in TGF-beta-induced transcriptional activity.
Wu D et al.
Molecular and Cellular Endocrinology, 2001
Select a paper to view details